Source |
Alliance of Genome Resources |
Category | ID | Classification term | Gene | Evidence | Inferred from | Organism | Reference |
---|---|---|---|---|---|---|---|
Molecular Function | GO:0001851 | complement component C3b binding | CR1 | IDA | Human | PMID:2972794 | |
Molecular Function | GO:0004877 | complement component C3b receptor activity | CR1 | IDA | Human | PMID:2972794 | |
Molecular Function | GO:0001855 | complement component C4b binding | CR1 | IDA | Human | PMID:2972794 | |
Molecular Function | GO:0001861 | complement component C4b receptor activity | CR1 | IDA | Human | PMID:2972794 | |
Molecular Function | GO:0005515 | protein binding | CR1 | IPI | UniProtKB:Q12923 | Human | PMID:18684861 |
Molecular Function | GO:0005515 | protein binding | CR1 | IPI | UniProtKB:O75636 | Human | PMID:23460739 |
Molecular Function | GO:0005515 | protein binding | CR1 | IPI | UniProtKB:P11226 | Human | PMID:23460739 |
Molecular Function | GO:0005515 | protein binding | CR1 | IPI | UniProtKB:Q15485 | Human | PMID:23460739 |
Molecular Function | GO:0005515 | protein binding | CR1 | IPI | UniProtKB:P11226 | Human | PMID:29563915 |
Molecular Function | GO:0005515 | protein binding | CR1L | IPI | UniProtKB:Q8NEL9-2 | Human | PMID:32296183 |
Cellular Component | GO:0016323 | basolateral plasma membrane | Cr1l | IDA | Mouse | PMID:20675597 | |
Cellular Component | GO:0009986 | cell surface | CR1 | IDA | Human | PMID:2972794 | |
Cellular Component | GO:0009986 | cell surface | CR1 | IDA | Human | PMID:6978375 | |
Cellular Component | GO:0009986 | cell surface | CR1 | IDA | Human | PMID:25742728 | |
Cellular Component | GO:0009986 | cell surface | Cr1l | IDA | Mouse | PMID:20675597 | |
Cellular Component | GO:0005856 | cytoskeleton | CR1 | IDA | Human | PMID:18684861 | |
Cellular Component | GO:0009897 | external side of plasma membrane | Cr1l | IDA | Mouse | PMID:18947875 | |
Cellular Component | GO:0070062 | extracellular exosome | CR1 | HDA | Human | PMID:19056867 | |
Cellular Component | GO:0070062 | extracellular exosome | CR1 | HDA | Human | PMID:23533145 | |
Cellular Component | GO:0005886 | plasma membrane | CR1 | IDA | Human | PMID:6910481 | |
Cellular Component | GO:0044853 | plasma membrane raft | CR1 | IDA | Human | PMID:24022490 | |
Cellular Component | GO:0043235 | receptor complex | CR1L | IDA | Human | PMID:23382219 | |
Biological Process | GO:1904669 | ATP export | CR1 | IDA | Human | PMID:24022490 | |
Biological Process | GO:0071456 | cellular response to hypoxia | Cr1l | IDA | Mouse | PMID:20675597 | |
Biological Process | GO:0006956 | complement activation | Cr1l | IMP | Mouse | PMID:20675597 | |
Biological Process | GO:0006957 | complement activation, alternative pathway | CR1 | IMP | Human | PMID:11981823 | |
Biological Process | GO:0002430 | complement receptor mediated signaling pathway | CR1 | IDA | Human | PMID:16360013 | |
Biological Process | GO:0002430 | complement receptor mediated signaling pathway | CR1 | IDA | Human | PMID:22962438 | |
Biological Process | GO:0002435 | immune complex clearance by erythrocytes | CR1 | IDA | Human | PMID:24022490 | |
Biological Process | GO:0001701 | in utero embryonic development | Cr1l | IGI | MGI:MGI:88233 | Mouse | PMID:18947875 |
Biological Process | GO:0001971 | negative regulation of activation of membrane attack complex | CR1 | IDA | Human | PMID:31862673 | |
Biological Process | GO:0045916 | negative regulation of complement activation | CR1 | IDA | Human | PMID:31862673 | |
Biological Process | GO:0045916 | negative regulation of complement activation | Cr1l | IMP | MGI:MGI:2158683 | Mouse | PMID:10642554 |
Biological Process | GO:0045916 | negative regulation of complement activation | Cr1l | IMP | Rat | PMID:11861390|RGD:625470 | |
Biological Process | GO:0045957 | negative regulation of complement activation, alternative pathway | CR1 | IDA | Human | PMID:10531307 | |
Biological Process | GO:0045959 | negative regulation of complement activation, classical pathway | CR1 | IDA | Human | PMID:10531307 | |
Biological Process | GO:0045959 | negative regulation of complement activation, classical pathway | CR1 | IDA | Human | PMID:6910481 | |
Biological Process | GO:1903660 | negative regulation of complement-dependent cytotoxicity | CR1 | IDA | Human | PMID:31862673 | |
Biological Process | GO:0002638 | negative regulation of immunoglobulin production | CR1 | IDA | Human | PMID:22962438 | |
Biological Process | GO:0032703 | negative regulation of interleukin-2 production | CR1 | IDA | Human | PMID:16360013 | |
Biological Process | GO:1900099 | negative regulation of plasma cell differentiation | CR1 | IDA | Human | PMID:22962438 | |
Biological Process | GO:1900004 | negative regulation of serine-type endopeptidase activity | CR1 | IDA | Human | PMID:6910481 | |
Biological Process | GO:0042130 | negative regulation of T cell proliferation | CR1 | IDA | Human | PMID:16360013 | |
Biological Process | GO:0032689 | negative regulation of type II interferon production | CR1 | IDA | Human | PMID:16360013 | |
Biological Process | GO:0007009 | plasma membrane organization | CR1 | IDA | Human | PMID:24022490 | |
Biological Process | GO:0001970 | positive regulation of activation of membrane attack complex | CR1 | IMP | Human | PMID:11981823 | |
Biological Process | GO:0008284 | positive regulation of cell population proliferation | CR1 | IDA | Human | PMID:25742728 | |
Biological Process | GO:0045591 | positive regulation of regulatory T cell differentiation | CR1 | IDA | Human | PMID:25742728 | |
Biological Process | GO:1900005 | positive regulation of serine-type endopeptidase activity | CR1 | IDA | Human | PMID:2972794 | |
Biological Process | GO:0030449 | regulation of complement activation | CR1L | IDA | Human | PMID:25284781 | |
Biological Process | GO:0030449 | regulation of complement activation | Cr1l | IMP | MGI:MGI:2158683 | Mouse | PMID:18947875 |
Biological Process | GO:1903659 | regulation of complement-dependent cytotoxicity | CR1L | IDA | Human | PMID:25284781 |
EXP Inferred from experiment |
IDA Inferred from direct assay |
IEP Inferred from expression pattern |
IGI Inferred from genetic interaction |
IMP Inferred from mutant phenotype |
IPI Inferred from physical interaction |
HTP Inferred from High Throughput Experiment |
HDA Inferred from High Throughput Direct Assay |
HMP Inferred from High Throughput Mutant Phenotype |
HGI Inferred from High Throughput Genetic Interaction |
HEP Inferred from High Throughput Expression Pattern |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/05/2024 MGI 6.24 |
|
|